Project: Innovative Diagnostic RNA sequencing Platform to improve ovarian cancer outcomes

OneRNA4OvaCure aims at seizing a major market opportunity by setting up a new rational method using an innovative RNA sequencing platform (OneRNA) to select the most effective treatment for Ovarian Cancer patients, with a strong focus on immune therapies. OneRNA4OvaCure will deliver an optimized RNA sequencing platform able to identify and quantify all expressed ovarian cancer drug targets and gene expression signatures that could guide treatment decisions.

Acronym OneRNA4OvaCure (Reference Number: 10591)
Duration 01/09/2016 - 01/09/2019
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 5

Project partner

Number Name Role Country
24596 Genomic Expression ApS Coordinator Denmark
24597 OvaCure Partner Denmark
24598 PubGene AS Partner Norway